资讯
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year. This company’s epinephrine nasal spray reverses allergic reactions—no ...
"Our strong execution throughout 2024 and into 2025 has positioned ARS Pharma for sustained growth and meaningful near-term value creation. The successful U.S. commercial launch of neffy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果